Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-17 · accession 0000899243-22-007203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-17 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | F - Tax | $232.51 | -3,439 | 54.0K | -6% | -$799.6K | |
| M | 2022-02-22 | 2022-02-18 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale | $230.97 | -4,312 | 53.0K | -8% | -$995.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-17 | F | D | 3,439 | $232.51 | 53,999 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-18 | S | D | 600 | $231.85 | 50,725 | D | — | — | (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $231.85 (range $231.67 to $232.01). |
| 3 | Common | Common Stock | 2022-02-18 | S | D | 385 | $231.01 | 51,325 | D | — | — | (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $231.01 (range $230.66 to $231.43). |
| 4 | Common | Common Stock | 2022-02-18 | S | D | 1,303 | $230.05 | 51,710 | D | — | — | (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $230.05 (range $229.65 to $230.59). |
| 5 | Common | Common Stock | 2022-02-18 | S | D | 1,038 | $233.27 | 49,687 | D | — | — | (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $233.27 (range $232.91 to $233.50). |
| 6 | Common | Common Stock | 2022-02-18 | S | D | 986 | $229.22 | 53,013 | D | — | — | (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F2) Open market sales reported on this line occurred at a weighted average price of $229.22 (range $228.65 to $229.60). |